This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): DUPA-99mTc, DUPA-99m Tc, PSMA-Tc99m
EC0652 is a PSMA-targeted molecular imaging agent that is being developed to non-invasively identify tumors that express PSMA receptors. EC0652, also termed DUPA-99mTc, is a conjugate of a high affinity PSMA-targeting ligand, 2-[3-(1, 3-dicarboxy propyl)-ureido] pentanedioic acid (DUPA) to technetium 99m (99mTc).
- EC1169 (Endocyte)
Additional information available to subscribers only: